EFFECT OF CABERGOLINE ON GLUCOSE TOLERANCE AND WEIGHT IN PATIENTS WITH OBESITY

Abstract

Introduction: Global obesity rates are rising due to rapid urbanisation and sedentary
lifestyles, affecting health and economics. Modifications to one's way of life, medical
interventions, and surgical procedures are among the methods that can be utilised to manage
obesity. New dopaminergic drugs show promise, but regulatory hurdles remain. Dopamine
modulation may reduce metabolic dysfunctions, but more research is needed.
Aim and objectives: This study aims to examine the impact of Cabergoline on glucose
tolerance and weight in obese adults.